| Health / Medical Topics |
CC-5013
A drug that is similar to thalidomide, and is used to treat multiple myeloma and certain types of anemia. It is also used to treat mantle cell lymphoma that has come back or has not gotten better after other treatment. It is being studied in the treatment of other conditions and types of cancer. CC-5013 may help the immune system kill abnormal blood cells or cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent and a type of immunomodulating agent. Also called lenalidomide and Revlimid. (NCI Dictionary)
YOU MAY ALSO LIKE
An immunoglobulin derived from the single-chain antigen-binding domain (sFv) of the monoclonal antibody CC-49 with potential antineoplastic activity. The parent monoclonal…
A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to…
A drug that is a form of thalidomide, and is used to treat multiple myeloma that has not gotten better with other…
A second generation ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity. Based on the chemistry of SP600125, another…
A drug that is being studied in the treatment of cancer. It is similar but not identical to thalidomide. CC-1088 belongs to…
CC Cytokine Genes encode Beta Chemokines, CC-type dual-cysteine chemokines with adjacent cysteine residues in their primary sequence that act as chemoattractants for…
